Betahistine Trends and Forecast
The future of the global betahistine market looks promising with opportunities in the cerebral thrombosis and cerebral embolism markets. The global betahistine market is expected to grow with a CAGR of 5.4% from 2024 to 2030. The major drivers for this market are increasing prevalence of vertigo and meniereÄX%$%Xs disease and rising awareness towards the vestibular disorders, and on-going advancements in diagnostic techniques.
• Lucintel forecasts that 8mg is expected to witness the higher growth over the forecast period.
• Within this market, cerebral thrombosis is expected to witness the higher growth.
• North America is expected to witness the highest growth over the forecast period.
United States: Pharmaceutical companies like Pfizer and Teva have announced expansions in their Betahistine product lines, aiming to cater to the growing demand for treatments related to vertigo and MeniereÄX%$%Xs disease. The FDA has emphasized the need for enhanced safety protocols and efficacy studies.
United Kingdom: With an aging population, the UK government has set targets to increase access to Betahistine medications in primary care settings. Companies like Accord Healthcare and Mylan are actively working towards meeting these targets through increased production and distribution.
Germany: Bayer AG has announced research collaborations with academic institutions to develop innovative formulations of Betahistine, aligning with the German governmentÄX%$%Xs focus on fostering pharmaceutical innovation and exports.
Japan: Daiichi Sankyo and Takeda Pharmaceuticals are leading initiatives to introduce Betahistine-based therapies in Japan, in line with government efforts to address vertigo-related disorders among the aging population.
China: Government initiatives to improve healthcare access have led to increased demand for Betahistine medications. Domestic pharmaceutical companies like Jiangsu Hansoh Pharmaceutical Group are expanding their production capacities to meet this demand while focusing on quality assurance and regulatory compliance.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Betahistine by Segment
The study includes a forecast for the global betahistine by type, application, and region.
Betahistine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• 8mg
• 25mg
• Others
Betahistine Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Cerebral Thrombosis
• Cerebral Embolism
• Others
Betahistine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Betahistine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies betahistine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the betahistine companies profiled in this report include-
• TOWA PHARMACEUTICAL
• Nichi-Iko Pharmaceutical
• Takeda Pharmaceutical Company
• EA Pharma
• Disphar International
• Hennig Arzneimittel
• DOC Generici
• Ciclum Farma Unipessoal
• Mylan
• Orion Corporation
Recent Development in the Betahistine Market
Pfizer Inc. Launches New Betahistine Formulation: Pfizer Inc., a leading pharmaceutical company, announced the launch of a novel Betahistine formulation aimed at improving treatment outcomes for patients suffering from vertigo and MeniereÄX%$%Xs disease. The new formulation promises enhanced efficacy and better tolerability compared to existing options.
Novartis AG Receives FDA Approval for Betahistine Biosimilar: Novartis AG secured FDA approval for its biosimilar version of Betahistine, marking a significant milestone in increasing accessibility to this essential medication for patients in the United States. The approval is expected to drive competition in the market and lower treatment costs.
Merck & Co. Collaborates with Academic Research Institutions for Betahistine Research: Merck & Co. announced collaborations with several academic research institutions to explore the potential of Betahistine in treating conditions beyond vertigo like cognitive disorders and psychiatric illnesses. This initiative underscores the companyÄX%$%Xs commitment to expanding the therapeutic applications of Betahistine.
Teva Pharmaceutical Industries Expands Betahistine Manufacturing Capacity: Teva Pharmaceutical Industries revealed plans to expand its manufacturing capacity for Betahistine to meet the growing global demand. The expansion aims to ensure a stable supply of the medication and support healthcare systems worldwide.
Bristol Myers Squibb Invests in Betahistine Clinical Trials: Bristol Myers Squibb allocated significant resources to conduct advanced clinical trials investigating the efficacy of Betahistine in treating vestibular migraines. The trials, conducted in collaboration with leading research institutions, seek to provide evidence-based insights into BetahistineÄX%$%Xs potential as a treatment option for this debilitating condition.
Features of the Global Betahistine Market
Market Size Estimates: Betahistine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Betahistine market size by type, application, and region in terms of value ($B).
Regional Analysis: Betahistine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the betahistine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the betahistine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for betahistine market?
Answer: The global betahistine market is expected to grow with a CAGR of 5.4% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the betahistine market?
Answer: The major drivers for this market are increasing prevalence of vertigo and meniereÄX%$%Xs disease and rising awareness towards the vestibular disorders, and on-going advancements in diagnostic techniques.
Q3. What are the major segments for betahistine market?
Answer: The future of the betahistine market looks promising with opportunities in the cerebral thrombosis and cerebral embolism markets.
Q4. Who are the key betahistine market companies?
Answer: Some of the key betahistine companies are as follows:
• TOWA PHARMACEUTICAL
• Nichi-Iko Pharmaceutical
• Takeda Pharmaceutical Company
• EA Pharma
• Disphar International
• Hennig Arzneimittel
• DOC Generici
• Ciclum Farma Unipessoal
• Mylan
• Orion Corporation
Q5. Which betahistine market segment will be the largest in future?
Answer: Lucintel forecasts that 8mg is expected to witness the higher growth over the forecast period.
Q6. In betahistine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the betahistine market by type (8mg, 25mg, and others), application (cerebral thrombosis, cerebral embolism, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Betahistine Market, Betahistine Market Size, Betahistine Market Growth, Betahistine Market Analysis, Betahistine Market Report, Betahistine Market Share, Betahistine Market Trends, Betahistine Market Forecast, Betahistine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.